T-cells in Alzheimer's disease

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Alzheimer's disease (AD) is characterized by amyloid-beta (Abeta) plaques and activated brain inflammation.
• T-cells are increasingly recognized as activated in AD patients, present both peripherally and within the brain.

Purpose of the Study:

• To explore the potential role of T-cells in Alzheimer's disease pathogenesis.
• To review existing literature on T-cell activation profiles and numbers in AD patients.
• To discuss implications for Abeta immunotherapy and propose alternative therapeutic strategies.

Main Methods:

• Literature review of studies examining T-cell subsets in AD patients' circulation and brain.
• Analysis of T-cell involvement in Abeta immunotherapy-induced side effects.
• Consideration of T-cell contributions to AD pathogenesis using mouse models.

Main Results:

• Disturbed T-cell activation profiles and altered numbers of T-cell subsets are reported in AD patients.
• Activated T-cell infiltrates have been linked to aseptic meningoencephalitis in some patients undergoing Abeta immunotherapy.
• Mouse models offer a system to investigate T-cell roles in AD.

Conclusions:

• T-cells may play a significant, albeit controversial, role in Alzheimer's disease.
• Current Abeta immunotherapy strategies need careful consideration due to potential T-cell mediated adverse effects.
• Further research, including studies with AD mouse models, is crucial to elucidate T-cell functions in AD and develop safer treatments.